Reference: American Heart Association. (2017). Title of the article. Journal of the American Heart Association, 6. https://www.ahajournals.org Summary: The article published in the Journal of the American Heart Association (JAHA) in 2017 explores significant advancements in cardiovascular research. It discusses the role of genetics in heart disease, highlighting how specific genetic markers can predict susceptibility […]
Reference: World Health Organization. (2024). Mpox. Retrieved from https://www.who.int/news-room/fact-sheets/detail/mpox Summary: Mpox, formerly known as monkeypox, is a viral infection caused by the monkeypox virus, belonging to the Orthopoxvirus genus. The disease presents with symptoms such as fever, rash, headache, muscle pain, and swollen lymph nodes, lasting typically 2–4 weeks. Transmission occurs via close contact with
Reference: World Health Organization. (2024). Mpox global strategic preparedness and response plan. Geneva, Switzerland: Author. Retrieved from https://www.who.int/emergencies/en Summary: The World Health Organization’s Mpox Global Strategic Preparedness and Response Plan (2024) outlines a comprehensive approach to mitigate the resurgence of mpox outbreaks, especially in regions like the Democratic Republic of the Congo (DRC). Following the
Reference: Hulscher, N., Procter, B. C., Wynn, C., & McCullough, P. A. (2023). Clinical approach to post-acute sequelae after COVID-19 infection and vaccination. Cureus, 15(11), e49204. https://doi.org/10.7759/cureus.49204 Summary: The article explores the pathogenic characteristics of the SARS-CoV-2 spike protein and its potential role in post-acute sequelae following COVID-19 infection or vaccination. It highlights emerging evidence
Reference: Ribeiro da Silva, S. J., Kohl, A., Pena, L., & Pardee, K. (2023). Clinical and laboratory diagnosis of monkeypox (mpox): Current status and future directions. iScience, 26, 106759. https://doi.org/10.1016/j.isci.2023.106759 Summary: The resurgence of monkeypox (mpox) as a global health concern necessitates a comprehensive understanding of its clinical and laboratory diagnosis. This article reviews the
Reference: Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2023). Rethinking next-generation vaccines for coronaviruses, influenza viruses, and other respiratory viruses. Cell Host & Microbe, 31, 146–157. https://doi.org/10.1016/j.chom.2022.11.016 Summary: The authors discuss the challenges in developing effective vaccines for respiratory viruses like influenza and SARS-CoV-2. They highlight that these viruses replicate rapidly in
Reference: Britt, T. J., Correia, P., Hurley, P., Krohn, M., LaSala, T., Leavitt, R., Lumia, R., MacDonald, C. S., Nolan, P., Rulis, S., & Spector, B. (2022). Group Life COVID-19 Mortality Survey Report. Society of Actuaries Research Institute. Summary: The Group Life COVID-19 Mortality Survey Report, published in August 2022, analyses the impact of the
Reference: Author. (2022). Adverse mortality trends in U.S. using age stratified excess mortality. Retrieved from https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm#dashboard Summary: The article examines adverse mortality trends in the U.S. through age-stratified excess mortality analysis. It highlights a concerning shift whereby excess deaths among younger populations have significantly increased, while those among the elderly have declined, potentially due to
Reference: Hayek, S., Shaham, G., Ben-Shlomo, Y., Kepten, E., Dagan, N., Nevo, D., Lipsitch, M., Reis, B. Y., Balicer, R. D., & Barda, N. (2022). Indirect protection of children from SARS-CoV-2 infection through parental vaccination. Science, 375(6585), 1155–1159. https://doi.org/10.1126/science.abm3087 Summary: The article investigates the indirect protection conferred to unvaccinated children against SARS-CoV-2 through parental vaccination